Quantum Pharma is a service-led, niche pharmaceutical developer, manufacturer and supplier to the retail pharmacy, pharmaceutical wholesaler, hospital andhomecare markets. Quantum Pharma operates through three divisions incorporating eight business units across eight sites in the UK and Europe, offering a portfolio of innovative and synergistic products and services.
Comprising three business units (Quantum Pharmaceutical, UL Medicines and Quantum Aseptic Services,) which manufacture, procure and supply unlicensed medicines (specials) and special obtains.
2. Niche Pharmaceuticals
Comprising three business units (Colonis, Lamda and PERN Consumer Products) which develop and commercialise niche pharmaceutical products.
3. Medication Adherence
Comprising two business units (Protomed (which owns Biodose®) and Biodose Services®) which provide products and services to enhance the likelihood of a patient adhering to medication regime, patient-focused specialist services and services to pharmaceutical companies.
Confirmation of successful £15 million fundraise subject to shareholder approval
CEO appointment and Board Changes
Half year results for the six months to 31 July 2016
Trading Update and Notice of Half Year Results
Appointment of Corporate Communications Manager
Launch of Glycopyrronium Bromide Oral Solution
Company Registration No 06775418 | VAT Registration No 927583293
Powered by Kentico CMS for ASP.NET